| RIN1 |
RIN1: Ras and Rab interactor 1 |
CDC23 |
CDC23: Cell division cycle protein 23 homolog |
2.757 |
Evidence |
|
| HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
TAL1 |
TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 |
2.757 |
Evidence |
|
| MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
PI4KII |
PI4K2A: Phosphatidylinositol 4-kinase type 2-alpha |
2.757 |
Evidence |
|
| CDK6 |
CDK6: Cell division protein kinase 6 |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
2.757 |
Evidence |
|
| SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
STAT4 |
STAT4: Signal transducer and activator of transcription 4 |
2.757 |
Evidence |
|
| SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
CDK6 |
CDK6: Cell division protein kinase 6 |
2.757 |
Evidence |
|
| RRAD |
RRAD, RAD: GTP-binding protein RAD |
RELA |
RELA, NFKB3: Transcription factor p65 |
2.757 |
Evidence |
|
| CDK7 |
CDK7, MO15: Cell division protein kinase 7 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
2.757 |
Evidence |
|
| MRE11A |
MRE11A, HNGS1, MRE11: Double-strand break repair protein MRE11A |
PCAF |
PCAF: Histone acetyltransferase PCAF |
2.757 |
Evidence |
|
| MRE11A |
MRE11A, HNGS1, MRE11: Double-strand break repair protein MRE11A |
FKBP1A |
FKBP1A, FKBP1, FKBP12: FK506-binding protein 1A |
2.757 |
Evidence |
|
| RGS19 |
RGS19, GAIP, GNAI3IP: Regulator of G-protein signaling 19 |
GSK3A |
GSK3A: Glycogen synthase kinase-3 alpha |
2.757 |
Evidence |
|
| TMEM1 |
TMEM1, EHOC1: Transmembrane protein 1 |
KPNA2 |
KPNA2, RCH1, SRP1: Importin subunit alpha-2 |
2.757 |
Evidence |
|
| NR4A2 |
NR4A2, NOT, NURR1, TINUR: Orphan nuclear receptor NR4A2 |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
2.757 |
Evidence |
|
| WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
SHC1 |
SHC1, RP11-307C12.1-001, hCG_1997126: SHC |
2.757 |
Evidence |
|
| WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
GMFB |
GMFB: Glia maturation factor beta |
2.757 |
Evidence |
|
| CASP3 |
CASP3, CPP32: Caspase-3 precursor |
EHD2 |
EHD2, PAST2: EH domain-containing protein 2 |
2.757 |
Evidence |
|
| SMCX |
JARID1C, DXS1272E, SMCX, XE169: Histone demethylase JARID1C |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
2.757 |
Evidence |
|
| OPRD1 |
OPRD1, OPRD: Delta-type opioid receptor |
GRIN2A |
GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor |
2.757 |
Evidence |
|
| GGCX |
GGCX, GC: Vitamin K-dependent gamma-carboxylase |
CREBBP |
CREBBP, CBP: CREB-binding protein |
2.757 |
Evidence |
|
| BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
PCAF |
PCAF: Histone acetyltransferase PCAF |
2.757 |
Evidence |
|
| WEE1 |
WEE1: Wee1-like protein kinase |
CREBBP |
CREBBP, CBP: CREB-binding protein |
2.757 |
Evidence |
|
| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
DNM1 |
IPI00552861 |
2.757 |
Evidence |
|
| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
SNRK |
SNRK, KIAA0096, SNFRK: SNF-related serine/threonine-protein kinase |
2.757 |
Evidence |
|
| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
MEF2C |
MEF2C: Myocyte-specific enhancer factor 2C |
2.757 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
SYMPK |
SYMPK, SPK: Symplekin |
2.757 |
Evidence |
|